In addition, our results showed that inactivation of Akt/mTOR in OXI-treated CRC cells was attributed to downregulation of PRDX2, whose expression was positively associated with Akt phosphorylation 18. This evidence concerns the gene PRDX2 and colorectal carcinoma.